Company intelligence / Profile preview

VetBio Partners

Ownership: Private
Development stage: Preclinical

Overview

VetBio Partners is a privately held research and development consulting firm specializing in human and animal health. The company provides expertise to support the discovery and development of veterinary pharmaceutical products. Recently, it has been engaged by Immunis to provide consulting services for non-terminal preclinical safety studies addressing canine muscle atrophy using novel secretome technology.

Therapeutic areas: Neurology
Modalities: Secretome-based biologics
Industry: Consulting

Partnerships

Immunis (consulting partner on preclinical studies for canine muscle atrophy)

Beyond the preview

Go deeper on VetBio Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VetBio Partners.

Explore the full profile